IXC.AX
Price:
$0.115
Market Cap:
$8.64M
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Perth, Australia.
Industry
Biotechnology
IPO Date
2019-07-05
Stock Exchange
ASX
Ticker
IXC.AX
According to Invex Therapeutics Ltd’s latest financial reports and current stock price. The company's current ROE is -8.98%. This represents a change of -11.41% compared to the average of -10.14% of the last 4 quarters.
The mean historical ROE of Invex Therapeutics Ltd over the last ten years is -15.89%. The current -8.98% ROE has changed -43.50% with respect to the historical average. Over the past ten years (40 quarters), IXC.AX's ROE was at its highest in in the June 2024 quarter at 8.28%. The ROE was at its lowest in in the December 2023 quarter at -39.90%.
Average
-15.89%
Median
-13.77%
Minimum
-36.50%
Maximum
-2.03%
Discovering the peaks and valleys of Invex Therapeutics Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 578.87%
Maximum Annual ROE = -2.03%
Minimum Annual Increase = -68.52%
Minimum Annual ROE = -36.50%
| Year | ROE | Change |
|---|---|---|
| 2025 | -9.09% | -68.52% |
| 2024 | -28.87% | -20.92% |
| 2023 | -36.50% | 163.00% |
| 2022 | -13.88% | 94.94% |
| 2021 | -7.12% | -48.29% |
| 2020 | -13.77% | 578.87% |
The current ROE of Invex Therapeutics Ltd (IXC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-24.82%
5-year avg
-19.09%
10-year avg
-15.89%
Invex Therapeutics Ltd’s ROE is greater than Bio-Gene Technology Limited (-137.10%), greater than Vectus Biosystems Limited (-2425.76%), greater than Memphasys Limited (-86.37%), greater than Percheron Therapeutics Limited (-117.98%), greater than Intelicare Holdings Limited (-1086.20%), greater than Chimeric Therapeutics Limited (-167.90%), greater than Biotron Limited (-63.03%), greater than Acrux Limited (-268.28%), greater than Cann Group Limited (-1259.94%), less than Adherium Limited (757.14%),
| Company | ROE | Market cap |
|---|---|---|
| -137.10% | $7.63M | |
| -2425.76% | $5.87M | |
| -86.37% | $12.27M | |
| -117.98% | $8.70M | |
| -1086.20% | $11.00M | |
| -167.90% | $10.93M | |
| -63.03% | $3.32M | |
| -268.28% | $6.16M | |
| -1259.94% | $6.33M | |
| 757.14% | $7.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invex Therapeutics Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Invex Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Invex Therapeutics Ltd's ROE?
How is the ROE calculated for Invex Therapeutics Ltd (IXC.AX)?
What is the highest ROE for Invex Therapeutics Ltd (IXC.AX)?
What is the 3-year average ROE for Invex Therapeutics Ltd (IXC.AX)?
What is the 5-year average ROE for Invex Therapeutics Ltd (IXC.AX)?
How does the current ROE for Invex Therapeutics Ltd (IXC.AX) compare to its historical average?